• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Rival sharps disposal company Daniels Sharpsmart sues Becton Dickinson

Rival sharps disposal company Daniels Sharpsmart sues Becton Dickinson

November 3, 2015 By Brad Perriello

Becton Dickinson, Daniels SharpsmartDaniels Sharpsmart, a rival to Becton Dickinson & Co. (NYSE:BDX) in the sharps disposal market, wants a federal judge in Chicago to force BD to retract a study allegedly linking reusable sharps disposal units with higher rates of a deadly superbug infection.

Daniels alleges that BD commissioned an outside professional to run a survey of hospitals designed to connect reusable sharps containers – a market Daniels claimed to dominate – with higher rates of Clostridum difficile infections.

“This professional sampled hospitals and inquired about 1 thing: The specific containers (disposables or reusables) that they used. That is it. And based on this limited data, after applying them to known existing data regarding the hospitals’ respective rates of C. diff, BD caused an article titled ‘The Relationship between Different Types of Sharps Containers and C. difficile Infection Rates in Acute Care Hospitals’ to be published in the American Journal of Infection Control,” Daniels alleged in the lawsuit. “By its title alone, the article suggests that a relationship between the use of specific sharps containers (reusables) and the spread of C. diff in fact exists, when in reality C. diff spreads because of myriad reasons, such as wet, dirty, or improperly sanitized sharps containers (user error). None of those reasons has ever been independently linked to the specific type of sharps container used alone.”

“So despite there being no evidence whatsoever showing a link between reusable sharps containers and C. diff, BD’s funded study concludes as much. And this was all in an effort to deceptively market its own product – disposable sharps containers,” the lawsuit alleged. “As with any competitive industry, there is a right way to compete, and there is a wrong one. BD chose the latter.”

Daniels wants a judge in the U.S. District Court for Northern Illinois to compel BD to retract “the false ‘independent study'” and force it to “make disclosures that specifically disclaim that the study does not in any way relate to or implicate Daniels specifically – or demonstrate any concrete link between reusables and C. diff generally – and, enjoins BD from utilizing its ‘independent study’ for any competitive purpose whatsoever.”

Daniels is also seeking an unspecified amount of damages and a jury trial, according to its complaint.

Filed Under: Clinical Trials, Legal News Tagged With: becton dickinson, Daniels Sharpsmart

More recent news

  • SS Innovations completes first robotic telesurgery for weight loss
  • Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
  • Abbott earns Medicare win for TriClip TEER system
  • Judge says Johnson & Johnson Ethicon owes $76.6M to ChemImage after failed partnership
  • Aurora Spine begins first procedures with Aero lumbar fusion system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy